Scientists discover important new biomarker that could improve HER2 targeted cancer t

[News]

Scientists from the School of Pharmacy & Pharmaceutical Sciences, Trinity College Dublin have made a significant discovery of a new biomarker which may help overcome resistance to newer and more targeted anti-cancer drugs, such as Herceptin, for HER2 positive cancers. These findings may also help the early identification of patients who will benefit more from these treatments.

More... (http://www.news-medical.net/news/20140611/Scientists-discover-important-new-biomarker-that-could-improve-HER2-targeted-cancer-treatments.aspx)